| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.2 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.2 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |